Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 8.28 USD -1.19% Market Closed
Market Cap: 1.2B USD
Have any thoughts about
Aurinia Pharmaceuticals Inc?
Write Note

Aurinia Pharmaceuticals Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aurinia Pharmaceuticals Inc
Interest Income Expense Peer Comparison

Comparables:
B
DRUG
TH
RPTX
COV
EDT

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Interest Income Expense
$12.6m
CAGR 3-Years
182%
CAGR 5-Years
7%
CAGR 10-Years
21%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Interest Income Expense
-CA$5.6k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Interest Income Expense
-$10.1m
CAGR 3-Years
-19%
CAGR 5-Years
-21%
CAGR 10-Years
-52%
Repare Therapeutics Inc
NASDAQ:RPTX
Interest Income Expense
$13.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Covalon Technologies Ltd
XTSX:COV
Interest Income Expense
-CA$56.9k
CAGR 3-Years
58%
CAGR 5-Years
27%
CAGR 10-Years
1%
Spectral Medical Inc
TSX:EDT
Interest Income Expense
-CA$4.7m
CAGR 3-Years
-133%
CAGR 5-Years
-132%
CAGR 10-Years
N/A

See Also

What is Aurinia Pharmaceuticals Inc's Interest Income Expense?
Interest Income Expense
12.6m USD

Based on the financial report for Sep 30, 2024, Aurinia Pharmaceuticals Inc's Interest Income Expense amounts to 12.6m USD.

What is Aurinia Pharmaceuticals Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
21%

Over the last year, the Interest Income Expense growth was -10%. The average annual Interest Income Expense growth rates for Aurinia Pharmaceuticals Inc have been 182% over the past three years , 7% over the past five years , and 21% over the past ten years .

Back to Top